Msaouel, Pavlos
The University of Texas MD Anderson Cancer Center
4 papers on CoChatORCID 0000-0001-6505-8308
Most cited papers
- Verified
Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma
Gao, J., Navai, N., Alhalabi, O., Siefker-Radtke, A., Campbell, M. T., Tidwell, R. S., Guo, C. C., Kamat, A. M., Matin, S. F., Araujo, J. C., et al. (2020) · Nature Medicine
Bladder and Urothelial Cancer TreatmentsCancer Immunotherapy and Biomarkers
Cited by 318
- Verified
Determining issues of importance for the evaluation of quality of life and patient-reported outcomes in breast cancer: results of a survey of 1072 patients
Hollen, P. J., Msaouel, P., & Gralla, R. J. (2015) · Breast Cancer Research and Treatment
Cancer survivorship and careHealth Systems, Economic Evaluations, Quality of Life
Cited by 44
- Verified
Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma
Jammihal, T., Saliby, R. M., Labaki, C., Soulati, H., Gallegos, J., Peris, A., McCurry, D., Yu, C., Shah, V., Poduval, D., et al. (2025) · Nature Cancer
Cancer Immunotherapy and BiomarkersRenal cell carcinoma treatment
Cited by 38
- Verified
Belzutifan efficacy and tolerability in patients with sporadic metastatic clear cell renal cell carcinoma
Wang, E., Rupe, E. S., Mukhida, S. S., Johns, A. C., Campbell, M. T., Shah, A. Y., Zurita, A. J., Gao, J., Goswami, S., Jonasch, E., et al. (2025) · European Urology Focus
Renal cell carcinoma treatmentFerroptosis and cancer prognosis
Cited by 4
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free